Ecopetrol
EC
Petroleo Brasileiro SA Petrobras
PBR
Taylor Morrison Home
TMHC
Adobe
ADBE
KB Home
KBH
US Stock MarketDetailed Quotes
CDXS Codexis
- 4.660
- -0.330-6.61%
Trading Dec 30 15:05 ET
379.22MMarket Cap-5.30P/E (TTM)
4.970High4.660Low357.07KVolume4.940Open4.990Pre Close1.70MTurnover0.58%Turnover RatioLossP/E (Static)81.38MShares6.08052wk High5.17P/B288.91MFloat Cap2.53052wk Low--Dividend TTM62.00MShs Float42.010Historical High--Div YieldTTM6.21%Amplitude1.240Historical Low4.747Avg Price1Lot Size
About Codexis Company
Codexis, Inc. is an enzyme engineering company, which engages in the development and sale of therapeutics. It operates through the Performance Enzymes and Novel Biotherapeutics segments. The Performance Enzymes segment commercializes CodeEvolver protein engineering technology platform and products in the pharmaceuticals market. The Novel Biotherapeutics segment targets new opportunities to discover and improve biotherapeutic drug candidates. Its products include screening kits and Codex HiFi Hot Start DNA Polymerase. The company was founded in January 2002 and is headquartered in Redwood City, CA.
Company Profile
SymbolCDXS
Company NameCodexis
Listing DateApr 22, 2010
Issue Price13.00
Founded2002
CEODr. Stephen Dilly, M.B.B.S.,PhD
MarketNASDAQ
Employees174
Fiscal Year Ends12-31
Address200 Penobscot Drive
CityRedwood City
ProvinceCalifornia
CountryUnited States of America
Zip Code94063-4718
Phone1-650-421-8100
Websitehttp://www.codexis.com
Company Executives
- Name
- Position
- Salary
- Dr. Stephen Dilly, M.B.B.S.,PhD
- Chairman of the Board, President and Chief Executive Officer
- 3.12M
- Georgia L. Erbez
- Chief Financial Officer
- --
- Dr. Alison Moore, PhD
- Chief Technical Officer
- 190.00K
- Margaret Nell Fitzgerald
- Chief Legal and Compliance Officer, General Counsel and Secretary
- --
- Kevin Norrett, M.B.A.
- Chief Operating Officer
- 1.09M
- Dr. Jennifer L. Aaker, PhD
- Independent Director
- 160.00K
- Dr. Rahul Singhvi, Sc.D.
- Independent Director
- 196.73K
- Byron L. Dorgan
- Independent Director
- 222.75K
- Dr. Esther Martinborough, PhD
- Independent Director
- 175.00K
- David V. Smith, M.B.A.
- Independent Director
- 195.00K
- Dr. Raymond de Vre
- Independent Director
- --
- H. Stewart Parker
- Independent Director
- 180.00K
- Dennis P. Wolf
- Independent Director
- 190.00K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.